Age less than 18 
Clinical or laboratory evidence of systemic infection 
Current pregnancy as assessed by preoperative urine HCG test 
Serious, uncontrolled, non-malignant illness 
Malignant illness requiring systemic chemotherapy in the last 6 months 
Documented allergy to oxycodone, morphine sulfate or acetaminophen 
Contraindication to peripheral nerve blockade or general anesthesia including: 
1. patient refusal 
2. active infection at site of planned block 
3. documented allergy to any local or general anesthetic medications 
4. significant coagulopathy( prothrombin time >15 seconds, INR>1.5 
5. pre-existing neuropathy and medical conditions or deformities which would compromise block or anesthetic safety 
Planned pleurodesis 
Current use of high dose inhaled or systemic steroids 
Current use of Amiodarone (Cordarone) 
Morbid obesity (BMI=40kg/m2) 
Patients with clinically significant mental health issues such as psychosis requiring treatment with antipsychotic medications. 
Patients unable to consent 
Patients with active infections requiring antibiotics within one month of registration 
Participation in other clinical trials that may interfere with this study       
    

NCT00639795_exc_T1
Person
Age
NCT00639795_exc_T2
Value
less than 18
NCT00639795_exc_T4
Temporal
preoperative
NCT00639795_exc_T5
Measurement
urine HCG test
NCT00639795_exc_T6
Value
pregnancy
NCT00639795_exc_T7
Condition
pregnancy
NCT00639795_exc_T8
Condition
non-malignant illness
NCT00639795_exc_T9
Qualifier
uncontrolled
NCT00639795_exc_T10
Qualifier
Serious
NCT00639795_exc_T11
Condition
Malignant illness
NCT00639795_exc_T12
Procedure
systemic chemotherapy
NCT00639795_exc_T13
Temporal
in the last 6 months
NCT00639795_exc_T14
Drug
oxycodone
NCT00639795_exc_T15
Drug
morphine sulfate
NCT00639795_exc_T16
Drug
acetaminophen
NCT00639795_exc_T17
Condition
allergy
NCT00639795_exc_T18
Scope
oxycodone, morphine sulfate or acetaminophen
NCT00639795_exc_T19
Condition
Contraindication to peripheral nerve blockade
NCT00639795_exc_T20
Condition
Contraindication to general anesthesia
NCT00639795_exc_T24
Condition
coagulopathy
NCT00639795_exc_T25
Qualifier
significant
NCT00639795_exc_T26
Measurement
prothrombin time
NCT00639795_exc_T27
Value
>15 seconds
NCT00639795_exc_T28
Measurement
INR
NCT00639795_exc_T29
Value
>1.5
NCT00639795_exc_T30
Scope
prothrombin time >15 seconds, INR>1.5
NCT00639795_exc_T31
Condition
neuropathy
NCT00639795_exc_T32
Temporal
pre-existing
NCT00639795_exc_T34
Condition
pleurodesis
NCT00639795_exc_T36
Drug
steroids
NCT00639795_exc_T37
Qualifier
inhaled
NCT00639795_exc_T38
Qualifier
systemic
NCT00639795_exc_T39
Scope
inhaled or systemic
NCT00639795_exc_T40
Qualifier
high dose
NCT00639795_exc_T41
Temporal
Current
NCT00639795_exc_T42
Drug
Amiodarone
NCT00639795_exc_T43
Drug
Cordarone
NCT00639795_exc_T44
Temporal
Current
NCT00639795_exc_T45
Condition
Morbid obesity
NCT00639795_exc_T46
Measurement
BMI
NCT00639795_exc_T47
Value
40kg/m2
NCT00639795_exc_T48
Condition
mental health issues
NCT00639795_exc_T49
Condition
psychosis
NCT00639795_exc_T50
Drug
antipsychotic medications
NCT00639795_exc_T51
Procedure
treatment
NCT00639795_exc_T52
Qualifier
clinically significant
NCT00639795_exc_T53
Scope
clinically significant mental health issues such as psychosis
NCT00639795_exc_T55
Condition
infections
NCT00639795_exc_T56
Temporal
active
NCT00639795_exc_T57
Drug
antibiotics
NCT00639795_exc_T58
Temporal
within one month of registration